Literature DB >> 36117238

Traumatic axonal injury: neuropathological features, postmortem diagnostic methods, and strategies.

Qianling Chen1, Xuebing Chen1, Luyao Xu1, Rui Zhang1, Zhigang Li2, Xia Yue3, Dongfang Qiao4.   

Abstract

Traumatic brain injury (TBI) has high morbidity and poor prognosis and imposes a serious socioeconomic burden. Traumatic axonal injury (TAI), which is one of the common pathological changes in the primary injury of TBI, is often caused by the external force to the head that causes the white matter bundles to generate shear stress and tension; resulting in tissue damage and leading to the cytoskeletal disorder. At present, the forensic pathological diagnosis of TAI-caused death is still a difficult problem. Most of the TAI biomarkers studied are used for the prediction, evaluation, and prognosis of TAI in the living state. The research subjects are mainly humans in the living state or model animals, which are not suitable for the postmortem diagnosis of TAI. In addition, there is still a lack of recognized indicators for the autopsy pathological diagnosis of TAI. Different diagnostic methods and markers have their limitations, and there is a lack of systematic research and summary of autopsy diagnostic markers of TAI. Therefore, this study mainly summarizes the pathological mechanism, common methods, techniques of postmortem diagnosis, and corresponding biomarkers of TAI, and puts forward the strategies for postmortem diagnosis of TAI for forensic cases with different survival times, which is of great significance to forensic pathological diagnosis.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Biomarker; Diffuse axonal injury; Forensic pathology; Postmortem diagnosis; Traumatic axonal injury

Year:  2022        PMID: 36117238     DOI: 10.1007/s12024-022-00522-0

Source DB:  PubMed          Journal:  Forensic Sci Med Pathol        ISSN: 1547-769X            Impact factor:   2.456


  104 in total

Review 1.  Traumatic neuropathology.

Authors:  G S Pearl
Journal:  Clin Lab Med       Date:  1998-03       Impact factor: 1.935

Review 2.  Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.

Authors:  Regina C Armstrong; Amanda J Mierzwa; Genevieve M Sullivan; Maria A Sanchez
Journal:  Neuropharmacology       Date:  2015-05-09       Impact factor: 5.250

Review 3.  Traumatic brain injury: neuropathological, neurocognitive and neurobehavioral sequelae.

Authors:  Dragan Pavlovic; Sandra Pekic; Marko Stojanovic; Vera Popovic
Journal:  Pituitary       Date:  2019-06       Impact factor: 4.107

4.  Diffuse axonal injury in head injury: definition, diagnosis and grading.

Authors:  J H Adams; D Doyle; I Ford; T A Gennarelli; D I Graham; D R McLellan
Journal:  Histopathology       Date:  1989-07       Impact factor: 5.087

5.  Global hypoxia per se is an unusual cause of axonal injury.

Authors:  D Dolinak; C Smith; D I Graham
Journal:  Acta Neuropathol       Date:  2000-11       Impact factor: 17.088

Review 6.  Traumatic axonal injury: practical issues for diagnosis in medicolegal cases.

Authors:  J F Geddes; H L Whitwell; D I Graham
Journal:  Neuropathol Appl Neurobiol       Date:  2000-04       Impact factor: 8.090

7.  Therapy development for diffuse axonal injury.

Authors:  Douglas H Smith; Ramona Hicks; John T Povlishock
Journal:  J Neurotrauma       Date:  2013-02-14       Impact factor: 5.269

8.  Dilemmas concerning the diffuse axonal injury as a clinicopathological entity in forensic medical practice.

Authors:  N Davceva; V Janevska; B Ilievski; L Spasevska; Z Popeska
Journal:  J Forensic Leg Med       Date:  2012-05-16       Impact factor: 1.614

9.  Trials and tribulations of using beta-amyloid precursor protein immunohistochemistry to evaluate traumatic brain injury in adults.

Authors:  D I Graham; C Smith; R Reichard; P D Leclercq; S M Gentleman
Journal:  Forensic Sci Int       Date:  2004-12-16       Impact factor: 2.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.